Literature DB >> 28280618

Clinicopathologic study of neuroendocrine tumors of gastroenteropancreatic tract: a single institutional experience.

Megha S Uppin1, Shantveer G Uppin1, Chittiboyina Shiva Prasada Venkata Sunil1, Monalisa Hui1, Tara Roshni Paul1, Nagari Bheerappa2.   

Abstract

BACKGROUND: The gastroenteropancreatic neuroendocrine tumors (GEPNET) have a characteristic histologic appearance unrelated of the exact site of origin. However the behavior of these tumors are different in each of these sites. In this article we study the clinicopathological features of GEPNET. These tumors were classified and graded according to WHO 2010 criteria. The immunohistochemical (IHC) features were evaluated and the grade of the tumor was correlated with Ki67.
METHODS: A total of 40 cases of GEPNET diagnosed on biopsies as well as resected specimens were analyzed from January 2012 to June 2015.
RESULTS: There were 28 resected specimens and 12 biopsies. Majority of the gastric neuroendocrine tumors (NET) showed classic morphology of cells arranged in islands. There were 3 cases each of grade 1 and grade 2 and one was diagnosed as mixed adenoneuroendocrine carcinoma (MANEC). All the duodenal NET were well differentiated (grade 1). There were 8 cases in colon and rectum, of which 4 cases were grade 3 and 3 cases were grade 2. Majority of the pancreatic tumors were grade 1. The mean mitotic count along with ki67 had good correlation in NET of stomach, duodenum colon and rectum.
CONCLUSIONS: The most common site was small intestine followed by pancreas. Majority of the tumors were NET G1. Tumors from colorectal region were mostly NEC G3. There was a strong correlation by spearman correlation analysis between Ki67 and mitotic count and moderate correlation between ki67 and tumor grade as well as mitotic rate and tumor grade. Ki67 was helpful in grading these tumors.

Entities:  

Keywords:  Ki67; Neuroendocrine tumors (NET); grade

Year:  2017        PMID: 28280618      PMCID: PMC5334039          DOI: 10.21037/jgo.2016.12.08

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  19 in total

Review 1.  Composite papillary intestinal-type adenocarcinoma/poorly differentiated neuroendocrine carcinoma of the ampulla of Vater.

Authors:  F Vilardell; A Velasco; D Cuevas; J J Olsina; X Matias-Guiu
Journal:  J Clin Pathol       Date:  2010-11-20       Impact factor: 3.411

Review 2.  Neuroendocrine tumors of the luminal gastrointestinal tract.

Authors:  Andrea Grin; Catherine J Streutker
Journal:  Arch Pathol Lab Med       Date:  2015-06       Impact factor: 5.534

3.  Comparison of methods for proliferative index analysis for grading pancreatic well-differentiated neuroendocrine tumors.

Authors:  Pamela P Goodell; Alyssa M Krasinskas; Jon M Davison; Douglas J Hartman
Journal:  Am J Clin Pathol       Date:  2012-04       Impact factor: 2.493

4.  P53, KI-67, CD117 expression in gastrointestinal and pancreatic neuroendocrine tumours and evaluation of their correlation with clinicopathological and prognostic parameters.

Authors:  Elife Kımıloğlu Şahan; Nusret Erdoğan; İlknur Ulusoy; Ergün Samet; Ayşenur Akyıldız İğdem; Doğan Gönüllü
Journal:  Turk J Gastroenterol       Date:  2015-03       Impact factor: 1.852

5.  Immunohistochemical localization of neuron-specific enolase in gastroenteropancreatic neuroendocrine tumors. Correlation with tissue and serum levels of neuron-specific enolase.

Authors:  S Simpson; A I Vinik; P J Marangos; R V Lloyd
Journal:  Cancer       Date:  1984-10-01       Impact factor: 6.860

6.  Prognostic significance of neuroendocrine components in gastric carcinomas.

Authors:  Ji Y Park; Min-Hee Ryu; Young Soo Park; Hye Jin Park; Baek-Yeol Ryoo; Min Gyu Kim; Jeong Hwan Yook; Byung Sik Kim; Yoon-Koo Kang
Journal:  Eur J Cancer       Date:  2014-09-04       Impact factor: 9.162

7.  Neuroendocrine carcinomas arising in ulcerative colitis: coincidences or possible correlations?

Authors:  Roberto Grassia; Paolo Bodini; Paolo Dizioli; Teresa Staiano; Elena Iiritano; Guglielmo Bianchi; Federico Buffoli
Journal:  World J Gastroenterol       Date:  2009-09-07       Impact factor: 5.742

8.  Neuroendocrine tumors involving the gastroenteropancreatic tract: a clinicopathological evaluation of 773 cases.

Authors:  Bruna Estrozi; Carlos E Bacchi
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

9.  Epidemiology of carcinoid neoplasms in Vaud, Switzerland, 1974-97.

Authors:  F Levi; V C Te; L Randimbison; G Rindi; C La Vecchia
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

10.  Clinical validation of the gastrointestinal NET grading system: Ki67 index criteria of the WHO 2010 classification is appropriate to predict metastasis or recurrence.

Authors:  Takeshi Yamaguchi; Takahiro Fujimori; Shigeki Tomita; Kazuhito Ichikawa; Hiroyuki Mitomi; Kazuya Ohno; Yosuke Shida; Hiroyuki Kato
Journal:  Diagn Pathol       Date:  2013-04-22       Impact factor: 2.644

View more
  6 in total

1.  Neuroendocrine Carcinoma of Duodenum-an Uncommon Tumour at an Unusual Site.

Authors:  Palki Dewan; Shubha P Bhat; H L Kishan Prasad; Rajesh Ballal; K Sajitha
Journal:  Indian J Surg Oncol       Date:  2018-12-07

2.  Clinicopathologic profile of gastroenteropancreatic neuroendocrine neoplasms in a referral center of South India.

Authors:  Temjen Sunup Jamir; Bhawana Ashok Badhe; Norton Stephen; Bheemanathi Hanuman Srinivas; Biju Pottakkat
Journal:  Int J Clin Exp Pathol       Date:  2022-05-15

3.  Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin.

Authors:  Rebekka Mai; Daniel Kaemmerer; Tina Träger; Elisa Neubauer; Jörg Sänger; Richard P Baum; Stefan Schulz; Amelie Lupp
Journal:  Sci Rep       Date:  2019-03-13       Impact factor: 4.379

Review 4.  Mixed adenoneuroendocrine carcinoma of the hepatic bile duct: a case report and review of the literature.

Authors:  Sulai Liu; Zhendong Zhong; Meng Xiao; Yinghui Song; Youye Zhu; Bo Hu; Zengpeng Sun; Weimin Yi; Chuang Peng
Journal:  BMC Gastroenterol       Date:  2020-11-25       Impact factor: 3.067

5.  Clinicopathological Features of Neuroendocrine Tumors in Gastroenteropancreatic Tract: A Single Center Study.

Authors:  Zubaria Rafique; Aafia Qasim; Asma Zafar; Seemal Ali; Akhtar S Chughtai; Aribah Atiq
Journal:  Cureus       Date:  2022-07-28

6.  Combination of laparoscopy and endoscopy as an option for treatment patients with gastric neuroendocrine tumors.

Authors:  A G Kriger; D S Gorin; A R Kaldarov; S V Berelavichus; L A Marinova; G V Galkin
Journal:  J Surg Case Rep       Date:  2019-01-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.